Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.
Despite increasing concern about drug-resistant herpes simplex virus (HSV), antiviral susceptibility testing is not routinely performed by most clinical virology laboratories. This omission is in large part because the most widely accepted method, the plaque reduction assay (PRA), is cumbersome to p...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1995
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162728/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7574517/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.6.1287 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|